Cardiovascular Intervention and Therapeutics

, Volume 33, Issue 4, pp 338–344 | Cite as

In-hospital outcomes of acute myocardial infarction with cardiogenic shock caused by right coronary artery occlusion vs. left coronary artery occlusion

  • Yousuke Taniguchi
  • Kenichi SakakuraEmail author
  • Yusuke Adachi
  • Naoyuki Akashi
  • Yusuke Watanabe
  • Masamitsu Noguchi
  • Kei Yamamoto
  • Yusuke Ugata
  • Hiroshi Wada
  • Shin-ichi Momomura
  • Hideo Fujita
Original Article


In-hospital outcomes of acute myocardial infarction (AMI) with cardiogenic shock (CS) were still not satisfactory even in the primary percutaneous coronary intervention (PCI) era. The aim of this study was to compare in-hospital outcomes of AMI with CS caused by right coronary artery (RCA) occlusion vs. left coronary artery (LCA) occlusion. Consecutive 894 AMI patients from January 2010 to March 2015 were screened for inclusion. A total of 114 AMI patients with CS were included as the final study population, and were divided into the RCA group (n = 56) and LCA group (n = 58). The patient characteristics were compared between the two groups. Multivariate logistic regression analysis was performed to show whether the RCA group was associated with better outcomes even after controlling confounding factors. In-hospital mortality was significantly lower in the RCA group (8.9%) than in the LCA group (46.6%) (P < 0.001). The RCA group (vs. the LCA group) was inversely associated with in-hospital death (OR 0.08, 95% CI 0.02–0.21, P < 0.001) after controlling covariates. Aspartate transaminase value (per 50 U/L incremental: OR 1.22, 95% CI 1.03–1.45, P = 0.02), aging (per 10-year-old incremental: OR 2.14, 95% CI 1.26–3.63, P = 0.01) and using VA-ECMO (OR 22.13, 95% CI 5.22–93.90, P < 0.001) were also significantly associated with in-hospital death. In conclusion, among AMI patients with CS, IRA of RCA was significantly associated with the better in-hospital outcome.


Cardiogenic shock Acute coronary syndrome Infarct-related artery In-hospital outcome 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

This study was approved by the institutional review board, and written informed consent was waived because of the retrospective study design.


  1. 1.
    Lee JH, Park HS, Chae SC, Cho Y, Yang DH, Jeong MH, et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2009;104:182–9.CrossRefGoogle Scholar
  2. 2.
    Trzeciak P, Gierlotka M, Gasior M, Lekston A, Wilczek K, Slonka G, et al. Mortality of patients with ST-segment elevation myocardial infarction and cardiogenic shock treated by PCI is correlated to the infarct-related artery—results from the PL-ACS Registry. Int J Cardiol. 2013;166:193–7.CrossRefGoogle Scholar
  3. 3.
    Wohrle J, Brodie B, Witzenbichler B, Dudek D, Kornowski R, Metzger C, et al. Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery. Am J Cardiol. 2013;112:753–60.CrossRefGoogle Scholar
  4. 4.
    Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, et al. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am Heart J. 2008;156:44–56.CrossRefGoogle Scholar
  5. 5.
    El-Menyar A, Zubaid M, AlMahmeed W, Sulaiman K, AlNabti A, Singh R, et al. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. Am J Emerg Med. 2012;30:97–103.CrossRefGoogle Scholar
  6. 6.
    Kunadian V, Qiu W, Ludman P, Redwood S, Curzen N, Stables R, et al. Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society). JACC Cardiovasc Interv. 2014;7:1374–85.CrossRefGoogle Scholar
  7. 7.
    Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, et al. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67:739–47.CrossRefGoogle Scholar
  8. 8.
    Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv. 2016;9:341–51.CrossRefGoogle Scholar
  9. 9.
    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.CrossRefGoogle Scholar
  10. 10.
    Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, et al. Clinical presentation, management and outcome of Japanese patients with acute myocardial infarction in the Troponin Era—Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET). Circ J. 2015;79:1255–62.CrossRefGoogle Scholar
  11. 11.
    Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306:2684–93.CrossRefGoogle Scholar
  12. 12.
    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–67.CrossRefGoogle Scholar
  13. 13.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRefGoogle Scholar
  14. 14.
    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefGoogle Scholar
  15. 15.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–75.CrossRefGoogle Scholar
  16. 16.
    Kolte D, Khera S, Dabhadkar KC, Agarwal S, Aronow WS, Timmermans R, et al. Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction. Am J Cardiol. 2016;117:1–9.CrossRefGoogle Scholar
  17. 17.
    Lee SN, Hwang YM, Kim GH, Kim JH, Yoo KD, Kim CM, et al. Primary percutaneous coronary intervention ameliorates complete atrioventricular block complicating acute inferior myocardial infarction. Clin Interv Aging. 2014;9:2027–31.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Gorter TM, Lexis CP, Hummel YM, Lipsic E, Nijveldt R, Willems TP, et al. Right ventricular function after acute myocardial infarction treated with primary percutaneous coronary intervention (from the glycometabolic intervention as adjunct to primary percutaneous coronary intervention in ST-segment elevation myocardial infarction III trial). Am J Cardiol. 2016;118:338–44.CrossRefGoogle Scholar
  19. 19.
    Smarz K, Zaborska B, Jaxa-Chamiec T, Tysarowski M, Budaj A. Right ventricular systolic function as a marker of prognosis after ST-elevation inferior myocardial infarction 5-year follow-up. Int J Cardiol. 2016;221:549–53.CrossRefGoogle Scholar
  20. 20.
    Chen ZW, Yu ZQ, Yang HB, Chen YH, Qian JY, Shu XH, et al. Rapid predictors for the occurrence of reduced left ventricular ejection fraction between LAD and non-LAD related ST-elevation myocardial infarction. BMC Cardiovasc Disord. 2016;16:3.CrossRefGoogle Scholar
  21. 21.
    Lim HS, Andrianopoulos N, Sugumar H, Stub D, Brennan AL, Lim CC, et al. Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2015;195:259–64.CrossRefGoogle Scholar
  22. 22.
    Chen YS, Chao A, Yu HY, Ko WJ, Wu IH, Chen RJ, et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2003;41:197–203.CrossRefGoogle Scholar
  23. 23.
    Negi SI, Sokolovic M, Koifman E, Kiramijyan S, Torguson R, Lindsay J, et al. Contemporary use of veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock in acute coronary syndrome. J Invasive Cardiol. 2016;28:52–7.PubMedGoogle Scholar
  24. 24.
    Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–8.CrossRefGoogle Scholar
  25. 25.
    Lemaire A, Anderson MB, Lee LY, Scholz P, Prendergast T, Goodman A, et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 2014;97:133–8.CrossRefGoogle Scholar
  26. 26.
    Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O’Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation. 1988;78:1345–51.CrossRefGoogle Scholar
  27. 27.
    Ellis SG, O’Neill WW, Bates ER, Walton JA Jr, Nabel EG, Werns SW, et al. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1989;13:1251–9.CrossRefGoogle Scholar
  28. 28.
    Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation. 1995;91:873–81.CrossRefGoogle Scholar
  29. 29.
    Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211–9.CrossRefGoogle Scholar
  30. 30.
    Nguyen HL, Yarzebski J, Lessard D, Gore JM, McManus DD, Goldberg RJ. Ten-year (2001–2011) trends in the incidence rates and short-term outcomes of early versus late onset cardiogenic shock after hospitalization for acute myocardial infarction. J Am Heart Assoc. 2017;6:e005566.PubMedPubMedCentralGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2017

Authors and Affiliations

  • Yousuke Taniguchi
    • 1
  • Kenichi Sakakura
    • 1
    Email author
  • Yusuke Adachi
    • 1
  • Naoyuki Akashi
    • 1
  • Yusuke Watanabe
    • 1
  • Masamitsu Noguchi
    • 1
  • Kei Yamamoto
    • 1
  • Yusuke Ugata
    • 1
  • Hiroshi Wada
    • 1
  • Shin-ichi Momomura
    • 1
  • Hideo Fujita
    • 1
  1. 1.Division of Cardiovascular Medicine, Saitama Medical CenterJichi Medical UniversitySaitamaJapan

Personalised recommendations